Package 0002-4117-30
Brand: zyprexa
Generic: olanzapinePackage Facts
Identity
Package NDC
0002-4117-30
Digits Only
0002411730
Product NDC
0002-4117
Description
30 TABLET in 1 BOTTLE (0002-4117-30)
Marketing
Marketing Status
Brand
zyprexa
Generic
olanzapine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9073f34c-307c-4a3a-8273-580ef5742229", "openfda": {"nui": ["N0000175430"], "upc": ["0300024415300", "0300024116306", "0300024115309", "0300024420304", "0300024112308", "0300024117303"], "unii": ["N7U69T4SZR"], "rxcui": ["153046", "153047", "153048", "200034", "212405", "261337", "283639", "284514", "312076", "312077", "312078", "312079", "314154", "314155", "351107", "351108", "485968", "545353", "754503", "754504", "754505", "754506"], "spl_set_id": ["d5051fbc-846b-4946-82df-341fb1216341"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0002-4117-30)", "package_ndc": "0002-4117-30", "marketing_end_date": "20260524", "marketing_start_date": "19961001"}], "brand_name": "Zyprexa", "product_id": "0002-4117_9073f34c-307c-4a3a-8273-580ef5742229", "dosage_form": "TABLET", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "0002-4117", "generic_name": "Olanzapine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zyprexa", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/1"}], "application_number": "NDA020592", "marketing_category": "NDA", "marketing_end_date": "20260524", "marketing_start_date": "19961001"}